Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Scanning electron microscopy revealed four distinct hair root shapes in alopecia areata, suggesting a less invasive diagnostic method.

Yellow dots and short vellus hairs are key signs for diagnosing alopecia areata using trichoscopy.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.